Jennifer M. Kirk - Jun 30, 2021 Form 3 Insider Report for Medtronic plc (MDT)

Role
Chief Accounting Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
3
Date filed
7/1/2021, 06:15 PM
Next filing
Jul 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDT Ordinary Shares 7.1K Jun 30, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDT Performance Share Units Jun 30, 2021 Performance Share Units 3.37K Direct F1, F2, F3
holding MDT Stock Option (Right to Buy) Jun 30, 2021 Ordinary Shares 11.1K $111.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests on August 3, 2023.
F2 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,373 shares will be issued. The actual number of shares to be issued could range from a low of 675 at minimum performance to a high of 6,746 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.